Transplantation of bone marrow-derived endothelial progenitor cells attenuates myocardial interstitial fibrosis and cardiac dysfunction in streptozotocin-induced diabetic rats

International Journal of Molecular Medicine

Volumn 30, Issue 4, 2012, Pages 870-876

  Cheng, Yongxia ^a   Guo, Sufen ^a   Liu, Guibo ^a   Feng, Yukuan ^a   Yan, Bin ^a   Yu, Jianbo ^a   Feng, Kejian ^a   Li, Zhiqiang ^a  

^a MUDANJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Diabetic cardiomyopathy; Endothelial progenitor cell; Myocardial fibrosis; Oxidative stress

Indexed keywords

CASPASE 3; COLLAGEN TYPE 1; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P67;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BONE MARROW DERIVED ENDOTHELIAL PROGENITOR CELL TRANSPLANTATION; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENDOTHELIAL PROGENITOR CELL; EX VIVO STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HEART CATHETERIZATION; HEART FUNCTION; HEART MUSCLE FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL TRANSPLANTATION; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; ENDOTHELIAL CELLS; FIBROSIS; MALE; MYOCARDIUM; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; STEM CELLS; STREPTOZOCIN;

EID: 84866512580     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1083     Document Type: Article

References (42)

1. Battiprolu PK, Gillette TG, Wang ZV, Lavandero S and Hill JA: Diabetic cardiomyopathy: mechanisms and therapeutic targets. Drug Discov Today Dis Mech 7: e135-e143, 2010.
2. Hayat SA, Patel B, Khattar RS and Malik RA: Diabetic cardiomyopathy: mechanisms, diagnosis and treatment. Clin Sci (Lond) 107: 539-557, 2004. (Pubitemid 39627201)
3. Boudina S and Abel ED: Diabetic cardiomyopathy revisited. Circulation 115: 3213-3223, 2007. (Pubitemid 47012236)
4. Adeghate E: Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: a short review. Mol Cell Biochem 261: 187-191, 2004.
5. Aneja A, Tang WH, Bansilal S, Garcia MJ and Farkouh ME: Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121: 748-757, 2008.
6. Asahara T, Murohara T, Sullivan A, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967, 1997. (Pubitemid 27087709)
7. Hristov M, Erl W and Weber PC: Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23: 1185-1189, 2003. (Pubitemid 36871271)
8. Krenning G, Dankers PY, Drouven JW, et al: Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Am J Physiol Renal Physiol 296: F1314-F1322, 2009.
9. Chen JZ, Zhang FR, Tao QM, Wang XX and Zhu JH: Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 107: 273-280, 2004. (Pubitemid 39243886)
10. Avouac J, Uzan G, Kahan A, Boileau C and Allanore Y: Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 75: 131-137, 2008.
11. Muller-Ehmsen J, Braun D, Schneider T, et al: Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. Eur Heart J 29: 1560-1568, 2008. (Pubitemid 351881989)
12. Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7, 2001.
13. Allegra A, Coppolino G, Bolignano D, et al: Endothelial progenitor cells: pathogenetic role and therapeutic perspectives. J Nephrol 22: 463-475, 2009.
14. Sen S, McDonald SP, Coates PT and Bonder CS: Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) 120: 263-283, 2011.
15. Alev C, Ii M and Asahara T: Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases. Antioxid Redox Signal 15: 949-965, 2011.
16. Grisar JC, Haddad F, Gomari FA and Wu JC: Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent. Biomark Med 5: 731-744, 2011.
17. Georgescu A: Vascular dysfunction in diabetes: The endothelial progenitor cells as new therapeutic strategy. World J Diabetes 2: 92-97, 2011.
18. Kim KA, Shin YJ, Kim JH, et al: Dysfunction of endothelial progenitor cells under diabetic conditions and its underlying mechanisms. Arch Pharm Res 35: 223-234, 2012.
19. Jarajapu YP and Grant MB: The promise of cell-based therapies for diabetic complications: challenges and solutions. Circ Res 106: 854-869, 2010.
20. Georgescu A, Alexandru N, Constantinescu A, Titorencu I and Popov D: The promise of EPC-based therapies on vascular dysfunction in diabetes. Eur J Pharmacol 669: 1-6, 2011.
21. Grapensparr L, Olerud J, Vasylovska S and Carlsson PO: The therapeutic role of endothelial progenitor cells in Type 1 diabetes mellitus. Regen Med 6: 599-605, 2011.
22. Zhang SJ, Zhang H, Hou M, et al: Is it possible to obtain 'true endothelial progenitor cells' by in vitro culture of bone marrow mononuclear cells? Stem Cells Dev 16: 683-690, 2007. (Pubitemid 47378740)
23. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B and Case J: Endothelial progenitor cells: identity defined? J Cell Mol Med 13: 87-102, 2009.
24. Cheng Y, Liu G, Pan Q, Guo S and Yang X: Elevated expression of liver X receptor alpha (LXRalpha) in myocardium of streptozotocin-induced diabetic rats. Inflammation 34: 698-706, 2011.
25. Wichi R, Malfitano C, Rosa K, et al: Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovasc Diabetol 6: 14, 2007.
26. Devanesan AJ, Laughlan KA, Girn HR and Homer-Vanniasinkam S: Endothelial progenitor cells as a therapeutic option in peripheral arterial disease. Eur J Vasc Endovasc Surg 38: 475-481, 2009.
27. Prater DN, Case J, Ingram DA and Yoder MC: Working hypothesis to redefine endothelial progenitor cells. Leukemia 21: 1141-1149, 2007. (Pubitemid 46831802)
28. Hirschi KK, Ingram DA and Yoder MC: Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 1584-1595, 2008.
29. Gou X, He WY, Xiao MZ, et al: Transplantation of endothelial progenitor cells transfected with VEGF165 to restore erectile function in diabetic rats. Asian J Androl 13: 332-338, 2011.
30. Park JH, Yoon JY, Ko SM, et al: Endothelial progenitor cell transplantation decreases lymphangiogenesis and adverse myocardial remodeling in a mouse model of acute myocardial infarction. Exp Mol Med 43: 479-485, 2011.
31. Badorff C, Brandes RP, Popp R, et al: Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107: 1024-1032, 2003. (Pubitemid 36258727)
32. Zampetaki A, Kirton JP and Xu Q: Vascular repair by endothelial progenitor cells. Cardiovasc Res 78: 413-421, 2008. (Pubitemid 351769775)
33. Asbun J and Villarreal FJ: The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47: 693-700, 2006. (Pubitemid 43243087)
34. Sangidorj O, Yang SH, Jang HR, et al: Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model. Am J Physiol Renal Physiol 299: F325-F335, 2010.
35. Ma YY, Sun D, Li J and Yin ZC: Transplantation of endothelial progenitor cells alleviates renal interstitial fibrosis in a mouse model of unilateral ureteral obstruction. Life Sci 86: 798-807, 2010.
36. Liu F, Liu ZD, Wu N, et al: Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transpl 15: 1092-1100, 2009.
37. Cai L, Li W, Wang G, Guo L, Jiang Y and Kang YJ: Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51: 1938-1948, 2002. (Pubitemid 34564309)
38. Burlacu A: Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7: 249-257, 2003.
39. Kinnaird T, Stabile E, Burnett MS, et al: Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94: 678-685, 2004. (Pubitemid 38387752)
40. Urbich C, Aicher A, Heeschen C, et al: Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 39: 733-742, 2005. (Pubitemid 41464410)
41. Sen S, Merchan J, Dean J, et al: Autologous transplantation of endothelial progenitor cells genetically modified by adeno-associated viral vector delivering insulin-like growth factor-1 gene after myocardial infarction. Hum Gene Ther 21: 1327-1334, 2010.
42. Oelze M, Knorr M, Schuhmacher S, et al: Vascular dysfunction in streptozotocin-induced experimental diabetes strictly depends on insulin deficiency. J Vasc Res 48: 275-284, 2011.